Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve N Caritis

Showing results (11-20 of 283) with videos related to

Pageof 29
Sort By:
Obstetrics and Gynecology|July 2, 2013
A pharmacologic approach to the use of glyburide in pregnancySteve N Caritis, Mary F Hebert
The New England Journal of Medicine|August 3, 2007
Prevention of preterm deliveryHyagriv N Simhan, Steve N Caritis
American Journal of Obstetrics and Gynecology|September 30, 2017
Evaluation of 17-alpha hydroxyprogesterone caproate efficacyAlisse Hauspurg, Steve N Caritis, Raman Venkataraman
Drug and Alcohol Dependence|July 9, 2025
Buprenorphine and norbuprenorphine concentrations associated with clinical withdrawal during pregnancySteve N Caritis, Elizabeth E Krans, Raman Venkataramanan
Seminars in Perinatology|October 5, 2014
Oseltamivir for influenza in pregnancyRichard H Beigi, Raman Venkataramanan, Steve N Caritis
American Journal of Obstetrics and Gynecology|September 2, 2018
Defining the clinical response to 17-alpha hydroxyprogesterone caproateSteve N Caritis, Alisse Hauspurg, Raman Venkataramanan, et al.
American Journal of Obstetrics and Gynecology|March 5, 2013
Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproateSteve N Caritis, Yang Zhao, Joseph Bettinger, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 18, 2024
Optimizing drug therapy during pregnancy: a spotlight on population pharmacokinetic modelingPrerna Dodeja, Nupur Chaphekar, Steve N Caritis, et al.
American Journal of Obstetrics and Gynecology|May 7, 2013
Reply: To PMID 23453884Steve N Caritis, Yang Zhao, Raman Venkataramanan, et al.
JAMA Pediatrics|October 6, 2015
Glyburide vs Insulin and Adverse Pregnancy OutcomesMaisa N Feghali, Christina M Scifres, Steve N Caritis
Pageof 29

Showing results (11-20 of 283) with videos related to

Sort By:
Pageof 29
Obstetrics and Gynecology|July 2, 2013
A pharmacologic approach to the use of glyburide in pregnancySteve N Caritis, Mary F Hebert
The New England Journal of Medicine|August 3, 2007
Prevention of preterm deliveryHyagriv N Simhan, Steve N Caritis
American Journal of Obstetrics and Gynecology|September 30, 2017
Evaluation of 17-alpha hydroxyprogesterone caproate efficacyAlisse Hauspurg, Steve N Caritis, Raman Venkataraman
Drug and Alcohol Dependence|July 9, 2025
Buprenorphine and norbuprenorphine concentrations associated with clinical withdrawal during pregnancySteve N Caritis, Elizabeth E Krans, Raman Venkataramanan
Seminars in Perinatology|October 5, 2014
Oseltamivir for influenza in pregnancyRichard H Beigi, Raman Venkataramanan, Steve N Caritis
American Journal of Obstetrics and Gynecology|September 2, 2018
Defining the clinical response to 17-alpha hydroxyprogesterone caproateSteve N Caritis, Alisse Hauspurg, Raman Venkataramanan, et al.
American Journal of Obstetrics and Gynecology|March 5, 2013
Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproateSteve N Caritis, Yang Zhao, Joseph Bettinger, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 18, 2024
Optimizing drug therapy during pregnancy: a spotlight on population pharmacokinetic modelingPrerna Dodeja, Nupur Chaphekar, Steve N Caritis, et al.
American Journal of Obstetrics and Gynecology|May 7, 2013
Reply: To PMID 23453884Steve N Caritis, Yang Zhao, Raman Venkataramanan, et al.
JAMA Pediatrics|October 6, 2015
Glyburide vs Insulin and Adverse Pregnancy OutcomesMaisa N Feghali, Christina M Scifres, Steve N Caritis
Pageof 29